FNGU vs IBB
MicroSectors FANG+ Index 3X Leveraged ETN vs iShares Biotechnology ETF
- • FNGU has the lower expense ratio at 0.35% vs 0.44% for IBB.
- • IBB pays a higher dividend yield (0.16%).
Side-by-side metrics
| Metric | FNGU | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.35% | 0.44% |
Dividend yield Trailing 12-month yield. | 0.00% | 0.16% |
AUM Assets under management — bigger funds are typically more liquid. | $2.08B | $11.50B |
YTD return | -3.17% | 30.22% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.00 | 0.60 |
P/E ratio | 25.73 | 25.48 |
Last price | $25.86 | $217.75 |
Inception | — | — |
Issuer | MicroSectors | iShares |
FNGU top holdings
| PLTR | Palantir Technologies Inc Ordinary Shares - Class A | 11.45% |
| MSFT | Microsoft Corp | 10.99% |
| AAPL | Apple Inc | 10.67% |
| AVGO | Broadcom Inc | 10.33% |
| MU | Micron Technology Inc | 10.25% |
| NVDA | NVIDIA Corp | 10.15% |
| AMZN | Amazon.com Inc | 10.07% |
| META | Meta Platforms Inc Class A | 9.43% |
| GOOGL | Alphabet Inc Class A | 8.41% |
| NFLX | Netflix Inc | 8.25% |
IBB top holdings
| GILD | Gilead Sciences Inc | 8.94% |
| AMGN | Amgen Inc | 8.31% |
| VRTX | Vertex Pharmaceuticals Inc | 7.87% |
| REGN | Regeneron Pharmaceuticals Inc | 6.24% |
| MRNA | Moderna Inc | 5.49% |
| NTRA | Natera Inc | 3.78% |
| ARGX | argenx SE ADR | 3.36% |
| BIIB | Biogen Inc | 2.52% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.50% |
| ILMN | Illumina Inc | 2.41% |
About FNGU
FNGU (MicroSectors FANG+ Index 3X Leveraged ETN) is 3x leveraged exposure to FANG+ mega-cap tech names. Managed by MicroSectors, the fund carries $2.1B in assets under management, an expense ratio of 0.35%. Its largest holding is Palantir Technologies Inc Ordinary Shares - Class A (PLTR), which represents 11.5% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 10.1%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $11.5B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.16%. Its largest holding is Gilead Sciences Inc (GILD), which represents 8.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.